186 related articles for article (PubMed ID: 2305015)
1. Repeated exposure to diisopropylfluorophosphate (DFP) produces increased sensitivity to cholinergic antagonists in discrimination retention and reversal.
Raffaele K; Olton D; Annau Z
Psychopharmacology (Berl); 1990; 100(2):267-74. PubMed ID: 2305015
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
[TBL] [Abstract][Full Text] [Related]
3. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates.
McDonald BE; Costa LG; Murphy SD
Toxicol Lett; 1988 Jan; 40(1):47-56. PubMed ID: 3341049
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
[TBL] [Abstract][Full Text] [Related]
5. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
6. Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment.
Cioffi CL; el-Fakahany EE
Eur J Pharmacol; 1988 Oct; 156(1):35-45. PubMed ID: 2850209
[TBL] [Abstract][Full Text] [Related]
7. Effects of diisopropylfluorophosphate on brain cholinergic systems of rats at early developmental stages.
Michalek H; Pintor A; Fortuna S; Bisso GM
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S204-12. PubMed ID: 4092888
[TBL] [Abstract][Full Text] [Related]
8. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
Van de Kamp JL; Collins AC
Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
[TBL] [Abstract][Full Text] [Related]
9. Postnatal exposure to diisopropylfluorophosphate enhances discrimination learning in adult mice.
Kofman O; Sher T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):914-8. PubMed ID: 16616984
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic and opiate involvement in the antinociceptive effect of diisopropylfluorophosphate.
Costa LG; Murphy SD
Pharmacol Biochem Behav; 1986 Mar; 24(3):733-6. PubMed ID: 3010340
[TBL] [Abstract][Full Text] [Related]
11. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
Tien LT; Fan LW; Ma T; Loh HH; Ho IK
J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
[TBL] [Abstract][Full Text] [Related]
12. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate.
Cioffi CL; el-Fakahany EE
Eur J Pharmacol; 1986 Dec; 132(2-3):147-54. PubMed ID: 3816972
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the dorsomedial striatum in behavioral flexibility: role of muscarinic cholinergic receptors.
Ragozzino ME; Jih J; Tzavos A
Brain Res; 2002 Oct; 953(1-2):205-14. PubMed ID: 12384254
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of cholinergic agonists on memory.
Olton DS; Raffaele KC
NIDA Res Monogr; 1990; 97():37-47. PubMed ID: 2247139
[TBL] [Abstract][Full Text] [Related]
15. Discrimination and avoidance learning in adult mice following developmental exposure to diisopropylfluorophosphate.
Levi Y; Kofman O; Schwebel M; Shaldubina A
Pharmacol Biochem Behav; 2008 Feb; 88(4):438-45. PubMed ID: 17963829
[TBL] [Abstract][Full Text] [Related]
16. Assessment of acute behavioral toxicity of low doses of diisopropylfluorophosphate (DFP) in rats.
Nieminen SA; Sirkka U; Lecklin A; Heikkinen O; Ylitalo P
Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):617-23. PubMed ID: 1787768
[TBL] [Abstract][Full Text] [Related]
17. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster FP; Heath I; Hendrix JC; Shannon HE
J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
[TBL] [Abstract][Full Text] [Related]
18. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
Bushnell PJ; Kelly KL; Ward TR
J Pharmacol Exp Ther; 1994 Jul; 270(1):15-25. PubMed ID: 7518512
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):295-310. PubMed ID: 2256118
[TBL] [Abstract][Full Text] [Related]
20. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
Kumar G; Talpos J; Steckler T
Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
